Bayer AG

BAYN

DE000BAY0017

Pharmaceuticals

Real-time Estimate Tradegate Other stock markets 10:57:07 2025-07-08 am EDT			5-day change	1st Jan Change
27.14 ^EUR	+3.80%		+2.25%	+40.08%

09:32am	MHRA approves elinzanetant to treat moderate to severe vasomotor symptoms caused by menopause	RE
09:28am	UK Clears Bayer Medicine for Menopause-related Hot Flashes	MT

BAYER : Preparing for a weak(er) 2024

Published on 11/21/2023 at 04:01, updated on 11/21/2023 at 04:34

This Alphavalue article, the European leader in independent research, is only available to subscribers .

Alphavalue is exclusively on MarketScreener.
To unlock the article, SUBSCRIBE!

Already a customer? Log In

Latest news about Bayer AG

MHRA approves elinzanetant to treat moderate to severe vasomotor symptoms caused by menopause	09:32am	RE
UK Clears Bayer Medicine for Menopause-related Hot Flashes	09:28am	MT
Bayer Treats First Patient in Early-stage Trial for Retinal Disorder Drug Candidate	05:24am	MT
Bayer Ag and BlueRock Therapeutics LP Announces First Patient Receives Investigational Therapy in Phase 1/2a Clinical Trial of OpCT-001 for the Treatment of Primary Photoreceptor Diseases	04:20am	CI
Bayer: testing OpCT-001, an experimental cell therapy	04:12am	CF
Vincerx Pharma, Inc. and Vnrx, Inc Announces Termination of License Agreement with Bayer Aktiengesellschaft and Bayer Intellectual Property Gmbh	Jul. 07	CI
BAYER AG : JP Morgan gives a Neutral rating	Jul. 07	ZD
BAYER AG : Goldman Sachs keeps its Buy rating	Jul. 04	ZD
General Mills changing Nature Valley labels after lawsuit's herbicide claim	Jul. 01	RE
Bayer Announces Executive Changes for North America	Jul. 01	CI
BAYER AG : UBS reaffirms its Neutral rating	Jul. 01	ZD
BAYER AG : JP Morgan reiterates its Neutral rating	Jun. 30	ZD
European shares see monthly declines as markets eye trade developments	Jun. 30	RE
BAYER AG : Jefferies remains Neutral	Jun. 30	ZD
Supreme Court Seeks US Government Advice on Bayer's Glyphosate Appeal	Jun. 30	RE
Bayer Sees Request for US Solicitor General's Opinion in Weedkiller Case as 'Encouraging Step'	Jun. 30	MT
US Supreme Court seeks Justice Department views on Bayer's Roundup appeal	Jun. 30	RE
US Supreme Court seeks Justice Department views on Bayer's Roundup appeal	Jun. 30	RE
Bayer says U.S. Supreme Court asks solicitor general for opinion in glyphosate case	Jun. 30	RE
Bayer says U.S. Supreme Court asks solicitor general for opinion in glyphosate case	Jun. 30	RE
German Stocks Rise on EU-US Trade Deal Hopes	Jun. 27	MT
Berenberg leaves Bayer at 'Hold' – target €26	Jun. 27	DP
BAYER AG : Gets a Neutral rating from Berenberg	Jun. 27	ZD
Bayer: EU approves treatment for AMD and DMO	Jun. 27	CF
Bayer Wins EU Nod for Eylea Label Extension	Jun. 27	MT

Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.8%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (38.9%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.6%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.2%), Switzerland (1.2%), Europe/Middle East/Africa (23.6%), the United States (31.7%), North America (3.6%), China (7.7%), Asia/Pacific (9.6%), Brazil (9.3%) and Latin America (8.1%).

Employees

90,885

Sector

Pharmaceuticals

Calendar

Aug. 06 - Q2 2025 Earnings Release

More about the company